Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02722395 · ClinicalTrials.gov registry record

Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)

A clinical trial, sponsored by Duke University.

Completed
Registry status
5
Enrollment target

NCT02722395: Completed study, sponsored by Duke University.

NCT02722395 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02722395 has completed, sponsored by Duke University.

COMPLETED
Registry status
5 participants
Enrollment target

Study Summary

This study is a research and development initiative established to explore the use of magnetic resonance imaging (MRI) as a tool for managing organ motion of the liver in cancer patients planning procedures for stereotactic body radiation therapy (SBRT).

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2016-08
Est. Completion 2017-02-01
Duke University

1,725 total trials

What the finished NCT02722395 record still lists

NCT02722395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT02722395 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02722395 about?

NCT02722395 is a clinical study titled "Magnetic Resonance Imaging (MRI) Solely For Liver Stereotactic Body Radiation Therapy (SBRT)". This study is a research and development initiative established to explore the use of magnetic resonance imaging (MRI) as a tool for managing organ motion of the liver in cancer patients planning procedures for stereotactic body radiation therapy (SBRT).

What is the current status of trial NCT02722395?

This trial is currently completed. The enrollment target is 5 participants. The study started on 2016-08. Estimated completion is 2017-02-01.

Who is sponsoring clinical trial NCT02722395?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02722395, the US trial registry maintained by the National Library of Medicine. NCT02722395 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.